Organization
Peking Union Medical College Hospital
137 clinical trials
3 abstracts
Abstract
Pemetrexed and platinum with or without pembrolizumab for tyrosine kinase inhibitor (TKI)-resistant, EGFR-mutant, metastatic nonsquamous NSCLC: Phase 3 KEYNOTE-789 study.Org: National Taiwan University Hospital and National Taiwan University Cancer Center, Seoul National University Bundang Hospital, Istituto Europeo di Oncologia, Osaka International Cancer Institute, Osaka, Japan, Peking Union Medical College Hospital,
Abstract
Evolution and prognostic significance of HER-2 changes from primary to residual disease in patients with HER-2–negative breast cancer receiving neoadjuvant chemotherapy.Org: National Cancer Center Hospital East, Kashiwa, Japan, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking Union Medical College Hospital,
Clinical trial
Health Economic Research on Oral Nutritional Supplements for Hospitalized Patients With Nutritional RiskStatus: Not yet recruiting, Estimated PCD: 2023-11-07
Abstract
Updated safety and efficacy data of combined KRAS G12C inhibitor (glecirasib, JAB-21822) and SHP2 inhibitor (JAB-3312) in patients with KRAS p.G12C mutated solid tumors.Org: Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China, Second Department of Thoracic Tumors, Peking University Cancer Hospital, Department of Medical Oncology, Harbin Medical University Cancer Hospital, Tongji Hospital, Tongji Medical College Huazhong University of Science and Technology,
Clinical trial
A Randomized, Controlled, Single-center Clinical Study of Lenvatinib in Combination With Tislelizumab With or Without TACE in First-line Treatment of Advanced Hepatocellular Carcinoma.Status: Recruiting, Estimated PCD: 2024-04-15
Clinical trial
A Single-center, Single-arm, Prospective Clinical Study on the Efficacy and Safety of Cyclosporine Combined With Avatrombopag in the Treatment of Non-severe Aplastic Anemia in the ElderlyStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Prospective, Single-armed Study to Evaluate the Efficacy and Safety of Neoadjuvant Pembrolizumab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma PatientsStatus: Completed, Estimated PCD: 2023-03-30
Clinical trial
A Phase II, Single-arm, Multicenter, Prospective Study of Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Evaluation of the Efficacy and Safety of Cardonilimab Injection Combined With TKI as Second-line Treatment for Advanced Hepatocellular Carcinoma: A Single-arm, Open-label, Multicenter Real-world Clinical StudyStatus: Recruiting, Estimated PCD: 2026-01-01
Clinical trial
First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Patients With Advanced Gastrointestinal Neuroendocrine Carcinoma: A Prospective Single-arm Phase II StudyStatus: Recruiting, Estimated PCD: 2026-11-30
Clinical trial
68Ga-P16-093 PET/CT Imaging in the Salivary GlandStatus: Not yet recruiting, Estimated PCD: 2023-12-30
Clinical trial
A Prospective Study of the Effect of Modified Colonoscopy Bowel Preparation Program on Intestinal Cleaning, Examination and Disease in Patients With Inflammatory Bowel DiseaseStatus: Recruiting, Estimated PCD: 2024-07-31
Clinical trial
A Prospective, Single Arm Study of Nimotuzumab Combined With NALIRIFOX in the Treatment of Locally Advanced Pancreatic CancerStatus: Active (not recruiting), Estimated PCD: 2027-05-01
Clinical trial
A Randomized, Controlled, Open-label, Multi-center Clinical Trial of Multi-kinase Inhibitor Combined With Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma and High-risk Recurrence Factors After Liver TransplantationStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
A Study on the Efficacy of Thyroid Hormone Replacement Therapy for Secondary Hypothyroidism Following Intracerebral HemorrhageStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
Efficacy of COVID-19 Booster-Dose Vaccine for Re-infection Precaution and Dynamics of Specific Serum Antibodies in the Management of Lung Cancer Patients With Systemic Anti-cancer TreatmentStatus: Recruiting, Estimated PCD: 2026-12-08
Clinical trial
A Single-arm Phase II Clinical Trial of Serplulimab Combined With Concurrent Chemoradiotherapy for Limited-stage Small Cell Lung Cancer(LS-SCLC).Status: Not yet recruiting, Estimated PCD: 2027-01-25
Clinical trial
A Single-arm, Single-center, Prospective, Phase II Study of Nimotuzumab, Tislelizumab Plus Radiotherapy for Recurrent and Metastatic Cervical CancerStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Clinical trial
Efficacy and Safety of Toripalimab Plus Actinomycin-D as Fist-Line Treatment in Patients With Gestational Trophoblastic Neoplasia With FIGO Score 7: A Single-Arm, Multicenter, Phase II TrialStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
The Exploratory Study on Clinical Rational Use of Rivaroxaban Dosing in Elderly Chinese PopulationStatus: Recruiting, Estimated PCD: 2026-09-30
Clinical trial
Phase I/II Study of Linperlisib in Combination With Chidamide for Relapsed and Refractory Peripheral T-cell Lymphoma: a Prospective, Multi-center StudyStatus: Recruiting, Estimated PCD: 2024-09-25
Clinical trial
A Phase II, Multicenter, Randomized Study of Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract CancerStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Phase 1 Trial Assessing Safety, Maximum Tolerated Dose, and Patient-Specific Dosimetry of [177Lu]Lu-LNC1011 in Metastatic Castration-Resistant ProstateStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
Efficacy and Safety of Tirofiban in Patients With Acute Branch Atheromatous Disease (BAD)- Related Stroke (BRANT)Status: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
An Exploratory Study to Evaluate the Efficacy of Anlotinib Hydrochloride Combined With Penpulimab in the Treatment of Radioiodine Refractory Differentiated Thyroid Cancer With First-line Resistance to Angiogenesis InhibitorsStatus: Not yet recruiting, Estimated PCD: 2024-12-20
Clinical trial
A Single-arm, Single Center, Phase II Study of RC48 Combined With Tislelizumab for Second-line Treatment of HER2 Expression in Recurrent Cervical CancerStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Prospective Randomized Controlled Study of the Effects of Different Therapy Regimens on Menopausal Sleep DisordersStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Multicenter, Single-Arm Pilot Study of Immune Checkpoint Inhibitors in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Who Had Long-Term (Two Years or Longer) Response to First-Line ImmunotherapyStatus: Not yet recruiting, Estimated PCD: 2027-01-10
Clinical trial
An Exploratory Clinical Study on Bortezomib for the Treatment of Refractory Rheumatoid ArthritisStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer PatientsStatus: Not yet recruiting, Estimated PCD: 2027-04-19
Clinical trial
The Study of Monitoring and Dosing Guidance of Direct Oral Anticoagulants Based on Pharmacokinetics, Pharmacodynamics, and PharmacogenomicsStatus: Recruiting, Estimated PCD: 2026-10-30
Clinical trial
The Effects of Ferric Derisomaltose on Postoperative Anemia in Patients Undergoing Spinal Deformity Surgery: A Prospective Randomized Controlled StudyStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
A Study of 18F-MFBG Imaging for the Tumor Burden Evaluation or Diagnostic Performance in Pheochromocytoma, Paraganglioma and Neuroblastoma.Status: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
Exploratory Study on the Therapeutic Effect Prediction Model of Immune Checkpoint Inhibitors for Advanced Biliary Tract CancerStatus: Active (not recruiting), Estimated PCD: 2023-12-30
Clinical trial
A Prospective, Multicenter, Phase III, Non-randomized Study of Tucidinostat, Azacitidine Combined With CHOP Versus CHOP in Patients With Untreated Peripheral T-cell LymphomaStatus: Recruiting, Estimated PCD: 2024-05-30
Clinical trial
Irinotecan Liposome II in Combination With 5-FU/LV and Oxaliplatin in Perioperative Treatment of Borderline Resectable Pancreatic Cancer：A Prospective, Single-arm, Multicenter, Phase II StudyStatus: Not yet recruiting, Estimated PCD: 2026-04-30
Clinical trial
An Open, One-arm, Prospective Study of a Single Dose Anti-CD20 Monoclonal Antibody Combined With Bortezomib for Treatment of Relapsed Refractory Autoimmune Hemolytic AnemiaStatus: Completed, Estimated PCD: 2024-03-01
Clinical trial
Efficacy and Safety of Actinomycin-D With or Without Toripalimab as Fist-Line Treatment in Patients With Gestational Trophoblastic Neoplasia With FIGO Score 5-6: A Multicenter, Open-label, Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-08-01
Clinical trial
Efficacy of Neoadjuvant Immunotherapy for T4 Deficient Mismatch Repair (dMMR) Colon Cancer: A Prospective, Single-arm, Phase Ⅱ Clinical TrialStatus: Recruiting, Estimated PCD: 2025-02-10
Clinical trial
Clinical Characteristics, Prognosis and Biomarkers of Myasthenia Gravis: a Prospective Cohort Study in ChinaStatus: Recruiting, Estimated PCD: 2026-09-30
Clinical trial
Chemokine Receptor CXCR4-targeting PET Imaging for ThymomaStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
A Prospective, Single-arm PhaseⅡTrial of Neoadjuvant/Adjuvant Pembrolizumab Plus Platinum-doublet Chemotherapy (Chemo) in IIa-IIIb NSCLCStatus: Active (not recruiting), Estimated PCD: 2023-12-08
Clinical trial
Phase II Randomized Window of Opportunity Trial of Chemoradiotherapy Alone Versus Combination With Metformin in Locally Advanced Cervical CancerStatus: Not yet recruiting, Estimated PCD: 2025-08-01
Clinical trial
A Prospective, Randomized Controlled Study to Evaluate the Efficacy and Safety of Durvalumab Combined With Neoadjuvant Therapy in Patients With Local Advanced Esophageal Squamous Cell CarcinomaStatus: Completed, Estimated PCD: 2023-12-01
Clinical trial
Efficacy of Mycophenolate Mofetil Versus Leflunomide as Maintenance Treatment for IgG4-RD Patients With Internal Organ InvolvementStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
An Open, Single-center, Multiple-dose, Dose-increasing and Dose-expanding Clinical Study to Observe and Evaluate the Safety, Tolerance, Immunokinetics and Preliminary Effectiveness of ABOR2014 Injection (IPM511) in the Treatment of Advanced Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract CancerStatus: Recruiting, Estimated PCD: 2025-03-06
Clinical trial
A Prospective Phase II Clinical Trial of Lenvatinib in Combination With Toripalimab for Patients With Platinum-Resistant Recurrent Ovarian CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Single-arm, Open-label Clinical Study on the Safety, Tolerability, and Preliminary Efficacy of MUC1 Therapeutic Tumor Vaccine in Advanced Solid CancersStatus: Not yet recruiting, Estimated PCD: 2023-12-01
Clinical trial
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast CancerStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
A Joint Real-World Study of Digital Smoking Cessation InterventionsStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Clinical trial
Establishment of an Efficacy and Relapse Prediction System for Immunosuppressants Combined With Thrombopoietin Receptor Agonists in the Treatment of Aplastic AnemiaStatus: Recruiting, Estimated PCD: 2025-01-30
Clinical trial
An Exploratory Study on Predicting the Efficacy of Dalpiciclib in Combination With Endocrine Therapy for HR-Positive and HER2-Negative Recurrent/Metastatic Breast Cancer Patients After CDK4/6 Inhibitor Treatment Failure Using 18F-FES PET/CTStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Construction of Diagnosis and Treatment System for Primary Vitreoretinal LymphomaStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Study of Two Different Treatment Strategies in IgG4-related Disease Patients With Re-elevation of Serum IgG4 Level During Maintenance Remission Period: a Randomized Double Blind Placebo Controlled Multicenter StudyStatus: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
Phase I/II Study of Linperlisib in Combination With Chidamide for Relapsed and Refractory Cutaneous T-cell Lymphoma: a Prospective, Single-center StudyStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory Myelodysplastic Syndrome With Ring Sideroblasts (MDS-RS): A Prospective Randomized Controlled StudyStatus: Not yet recruiting, Estimated PCD: 2024-08-01
Clinical trial
Vitro 3D Drug Sensitivity Detection of Micro Tumor (PTC) to Guide Postoperative Adjuvant Treatment Strategy and Prognosis Judgment of Colorectal Cancer--Prospective Clinical StudyStatus: Recruiting, Estimated PCD: 2025-09-30
Clinical trial
Sirolimus in the Treatment of Refractory/Relapsed Warm Autoimmune Hemolytic Anemia (AIHA)： a Phase 2 Prospective TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Ciclosporin + Antithymocyte Immunoglobulin + Avatrombpag Versus Ciclosporin + Avatrombpag for the Treatment of Severe Aplastic Anemia in the ElderlyStatus: Not yet recruiting, Estimated PCD: 2025-10-01
Clinical trial
Efficacy and Safety of AngongNiuhuang Pill in Patients With Acute Ischemic StrokeStatus: Completed, Estimated PCD: 2022-05-01
Clinical trial
Romiplostim in Combination With Ciclosporin Versus Ciclosporin in the Treatment of Newly Diagnosed Non-severe Aplastic AnemiaStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Clinical trial
DZD9008 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutations: Cohort StudyStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ABH2 SPECT/CTStatus: Recruiting, Estimated PCD: 2023-12-30
Clinical trial
Application of 68Ga-labeled ACE2 Targeting Probe PET/CT Imaging in Tracing ACE2 Expression and Diagnosis of Lung CancerStatus: Recruiting, Estimated PCD: 2023-12-12
Clinical trial
A Phase 2 Study of Pembrolizumab in Combination With Plinabulin and Docetaxel in Previously Treated Patients With Metastatic Non-Small Cell Lung Cancer and Progressive Disease (PD) After Immunotherapy (Anti-PD-1/PD-L1 Inhibitor) Alone or in Combination With Platinum-doublet Chemotherapy (KeyPemls-004)Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Safety and Dosimetry of 177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate CancerStatus: Completed, Estimated PCD: 2023-09-05
Clinical trial
A Prospective, Randomized, Controlled Study of rhTPO in Combination With Herombopag + CsA vs Herombopag + CsA for the Treatment of Primary Transfusion-dependent NSAAStatus: Not yet recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDSStatus: Not yet recruiting, Estimated PCD: 2025-10-01
Clinical trial
A Prospective, Multicenter and Registry-based Cohort Study of Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast CancerStatus: Recruiting, Estimated PCD: 2027-06-01
Clinical trial
Efficacy and Safety of Sivelestat Sodium and Dexamethasone in the Treatment of ARDS: a Pilot Study of a Prospective, Multicenter, Double-blind, Double-mock Randomized Controlled Clinical StudyStatus: Recruiting, Estimated PCD: 2025-06-01
Clinical trial
CLDN18.2 Targeted 68Ga-PMD22 PET Imaging in Patients With Gastrointestinal TumoursStatus: Recruiting, Estimated PCD: 2023-08-31
Clinical trial
Neoadjuvant Chemoradiation Plus Serplulimab in Patients With Locally Advanced Adenocarcinoma of Gastroesophageal Junction: a Single-arm,Open-label，Phase II Clinical StudyStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Prospective Single-center Study on the Efficacy and Safety of Lenalidomide Combined With Azacitidine vs Azacitidine in the Treatment of MDS-RSStatus: Not yet recruiting, Estimated PCD: 2024-08-01
Clinical trial
Efficacy and Safety of Comprehensive Treatment in Patients With Inflammation-associated Rapidly-progressive Coronary Artery Disease (IR-CAD): a Self-controlled Cohort StudyStatus: Recruiting, Estimated PCD: 2025-09-01
Clinical trial
CNCT19 Cell Injection for Refractory Systemic Lupus ErythematosusStatus: , Estimated PCD: 2024-05-30
Clinical trial
The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock PatientsStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
A Study on the Efficacy and Safety of Penpulimab in the Treatment of Metastatic Pheochromocytoma/Paraganglioma Patients Who Fail to Other Systemic TreatmentStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Single-cell Landscape of BALF in Patients With Severe ARDS and CARDS: an Analysis of the Effectiveness of Steroid Therapy and a Comparison Between COVID-19 ARDS and ARDS From Other EtiologiesStatus: Completed, Estimated PCD: 2023-02-09
Clinical trial
A Phase 2 Study of Anlotinib in Patients With Metastatic Pheochromocytoma or ParagangliomaStatus: Recruiting, Estimated PCD: 2023-10-17
Clinical trial
A Phase II Study of Pembrolizumab Plus Platinum and Pemetrexed as First Line Therapy in Advanced Non-squamous Non-small Cell Lung Cancer Patients With EGFR Exon 21 Point Mutation and Programmed Cell Death Ligand 1 ExpressionStatus: Not yet recruiting, Estimated PCD: 2027-11-30
Clinical trial
A Study on the Safety and Effectiveness of Anlotinib for Neoadjuvant Treatment of Locally Advanced, or Unresectable Pheochromocytoma or ParagangliomaStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Analyse of Diagnosis Value of Keloid on 68Ga- FAPI-04 PET-CTStatus: Completed, Estimated PCD: 2023-02-01
Clinical trial
The Efficacy and Safety of Corticosteroids in Combination With Biological Agents in the Management of Severe Immune Related Adverse Events Cohort A: The Efficacy and Safety of Corticosteroids or Corticosteroids Combination With Ruxolitinib in Patients With Severe Checkpoint Inhibitor PneumoniaStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
Efficacy and Safety of Elemene Plus Stupp Protocol Versus Stupp Protocol Alone for Newly-diagnosed Glioblastoma: A Multi-center Phase II Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2026-12-01
Clinical trial
99mTc-Labeled FAPI SPECT Imaging in Pulmonary FibrosisStatus: Recruiting, Estimated PCD: 2023-07-01
Clinical trial
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Borderline Resectable or Locally Advanced Pancreatic CancerStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
A Single-arm, Non-randomized, Single-center Study to Evaluate Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid CancerStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Study of the Key Techniques of Prevention and Treatment of Osteoporotic RefractureStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of Pheochromocytoma or Paraganglioma PatientsStatus: Recruiting, Estimated PCD: 2025-10-01
Clinical trial
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma: A Single Arm, Nonrandomized, Single Center Clinical StudyStatus: Recruiting, Estimated PCD: 2025-11-01
Clinical trial
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers: a Single-arm, Non-randomized, Single-center Clinical Trial and Biomarker StudyStatus: Recruiting, Estimated PCD: 2024-07-01
Clinical trial
Comparison of the Detection Efficiencies of Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT in Patients With Prostate CancerStatus: Recruiting, Estimated PCD: 2023-05-01
Clinical trial
Lenalidomide in the Treatment of Mucosal Behçet's SyndromeStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
The Administration Time Point of Carboprost Methylate and Effects on Perioperative Complications and Cervical Ripening Effect in Artificial AbortionStatus: Completed, Estimated PCD: 2022-12-31
Clinical trial
Exploratory Clinical Study on Induced Pluripotent Stem Cell Derived Exosomes (GD-iEXo-002) Nasal Drops for the Treatment of Refractory Focal EpilepsyStatus: Recruiting, Estimated PCD: 2025-06-13
Clinical trial
Anlotinib Plus Anti-PD-1 Antibody AK105 as Third or More-line Therapy for Advanced Pancreatic Cancer: a Prospective, Single-arm, Open-label, Pilot StudyStatus: Recruiting, Estimated PCD: 2024-02-28
Clinical trial
A Randomized Controlled Clinical Trial of Remimazolam Benzenesulfonate Usage in the Extraction of Impacted Wisdom TeethStatus: , Estimated PCD: 2023-04-01
Clinical trial
Neoadjuvant Toripalimab Plus Nimotuzumab in Primary Limited-Stage Oral Squamous Cell Carcinoma Prior to Radical Therapy：A Single-arm, Phase Ⅱ StudyStatus: Not yet recruiting, Estimated PCD: 2024-09-30
Clinical trial
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic CancerStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
Pilot Study of Tocilizumab Monotherapy for Active Chronic PeriaortitisStatus: Completed, Estimated PCD: 2022-12-30
Clinical trial
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic CancerStatus: Recruiting, Estimated PCD: 2026-02-01
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study of Apatinib in Locally Advanced or Metastatic Radioactive Iodine-refractory Differentiated Thyroid CancerStatus: Active (not recruiting), Estimated PCD: 2020-03-25
Clinical trial
An Open-Label, Multi-Center, Multiple-Dose, Dose-Escalation and Dose-Expansion, Investigator-Initiated Phase I Clinical Study to Observe and Evaluate the Tolerability, Safety, Pharmacodynamics, and Preliminary Efficacy of IPM001 Injection in the Treatment of Progressive Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma (BTC): a Single Arm, Prospective, Interventional Clinical StudyStatus: Not yet recruiting, Estimated PCD: 2025-04-30
Clinical trial
A Study of Telitacicept in the Treatment of Early Stage Systemic Lupus ErythematosusStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Efficacy and Safety of Tocilizumab and Tofacitinib in the Treatment of Patients With Vascular Behçet's SyndromeStatus: Not yet recruiting, Estimated PCD: 2026-06-01
Clinical trial
Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer: a Prospective Single-arm StudyStatus: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Single-arm, Open-label, Single-center Study to Evaluate the Safety and Tolerability of Intravenous GEN6050X Gene Therapy in Ambulatory Boys With Duchenne Muscular Dystrophy (DMD).Status: Not yet recruiting, Estimated PCD: 2025-12-01
Clinical trial
The Efficacy and Safety of Biktarvy in Treatment-Naïve Late Presenters With HIV-1 InfectionStatus: Active (not recruiting), Estimated PCD: 2022-12-13
Clinical trial
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung CancerStatus: Recruiting, Estimated PCD: 2023-12-31
Clinical trial
Exploratory Clinical Study on Induced Pluripotent Stem Cell Derived Exosomes (GD-iExo-001) for the Treatment of Atopic DermatitisStatus: Recruiting, Estimated PCD: 2025-04-30
Clinical trial
Pilot Clinical Evaluation of a Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell CarcinomaStatus: Completed, Estimated PCD: 2022-03-04
Clinical trial
Treatment Strategies for IgG4-RD Patients With Superficial Organ InvolvementStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Surufatinib Combined With Envafolimab Followed by Surufatinib as Second or More - Line Therapy for Advanced Soft Tissue Sarcoma in a Single-arm, Phase II StudyStatus: Not yet recruiting, Estimated PCD: 2026-02-02
Clinical trial
64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal CancerStatus: Recruiting, Estimated PCD: 2023-08-31
Clinical trial
Perioperative Percutaneous Electrical Nerve Stimulation Via a Wearable Equipment on Postoperative Nausea and Vomiting（PONV） in Patients Undergoing Laparoscopy Abdominal Surgery: a Prospective Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics ModelsStatus: Recruiting, Estimated PCD: 2024-05-01
Clinical trial
Real-world Study for Targeted Therapy and Immunotherapy in Patients With Advanced Hepatobiliary Tumors: a Multi-centers, Open-assess Observational Study.Status: Recruiting, Estimated PCD: 2023-10-01
Clinical trial
The Efficacy and Safety of Temozolomide in Patients With Metastatic Pheochromocytoma or ParagangliomaStatus: Completed, Estimated PCD: 2022-10-01
Clinical trial
Venetoclax Combined With Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis Patients With Translocation (11;14): A Multicenter Phase 2 StudyStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors: a Single-arm, Non-randomized, Single-center Phase II TrialStatus: Recruiting, Estimated PCD: 2024-01-01
Clinical trial
Lenvatinib Combined Toripalimab in Advanced Hepatocellular Carcinoma: a Single-center, Single-arm, Non-randomized Clinical StudyStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
A Single-arm, Non-randomized, Single-center Study to Evaluate Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced Hepatocellular CarcinomaStatus: Recruiting, Estimated PCD: 2024-08-01
Clinical trial
A Phase II, Multicenter, Randomized Study of Pembrolizumab With or Without Chemotherapy or Lenvatinib in First-Line Treatment of Advanced Biliary Tract CancerStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Lenvatinib Combined Pembrolizumab as a Second-line Treatment in Advanced Hepatobiliary Tumors: a Single-center, Single-arm, Non-randomized Clinical StudyStatus: Completed, Estimated PCD: 2021-04-01
Clinical trial
A Multi-center, Prospective, Open-label, Randomized Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome PatientsStatus: Active (not recruiting), Estimated PCD: 2024-08-22
Clinical trial
An Exploratory Study on the Efficacy and Safety of Lusutrombopag in the Treatment of Recurrent/Refractory/Intolerable NSAAStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Clinical trial
Therapeutic Efficiency and Response to 177Lu-AB-3PRGD2 in Patients With Integrin αVβ3 Positive TumorsStatus: Recruiting, Estimated PCD: 2024-10-30
Clinical trial
Rectal Indomethacin as Early Treatment for Acute Pancreatitis (INDOMAP Trial): Study Protocol for a Multi-center, Double-blinded, Placebo-controlled, Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2028-06-01
Clinical trial
A Prospective, Randomized Controlled Study to Compare the Effect of Sevoflurane and Propofol for Maintenance of Anesthesia on Postoperative Recovery After Transsphenoidal Resection of Pituitary AdenomaStatus: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
Effectiveness of Belimumab After Rituximab in Resistant Primary Juvenile Sjogren's SyndromeStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Bortezomib-lenalidomide-dexamethasone Combined With Radiotherapy for Newly Diagnosed Solitary PlasmacytomaStatus: Recruiting, Estimated PCD: 2026-04-01
Clinical trial
Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma：a Multicenter Prospective Single Arm TrialStatus: Recruiting, Estimated PCD: 2026-06-01
Clinical trial
Thrombopoietin Receptor Agonist (TPO-RA) Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationStatus: Recruiting, Estimated PCD: 2027-06-20
Clinical trial
A Study to Evaluate Glofitamab as Single Agent in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaStatus: Recruiting, Estimated PCD: 2027-12-31
Clinical trial
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor PatientsStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
A Pilot Study of 68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer PatientsStatus: Recruiting, Estimated PCD: 2025-12-31